Boston Scientific converts all Series A Preferred Stock into common; 24M shares issued

BOSTON SCIENTIFIC CORP

On June 1, 2023, all outstanding 5.50% Mandatory Convertible Preferred Stock (Series A) automatically converted into common stock.
Conversion rate: 2.3834 common shares per preferred share; cash paid for fractional shares.
Approximately 24 million common shares issued; no preferred shares remain outstanding.
Boston Scientific requested NYSE delisting and deregistration of the preferred stock.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.